These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 606017)

  • 1. Characterization of tumour virus proteins. II. Expression of the protein P30 in transformed productive and non-productive Ki/NRK cells.
    Higuchi T; August JT
    An Acad Bras Cienc; 1977; 49(2):337-47. PubMed ID: 606017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of tumour virus proteins. I. Radioimmunoassay of the P27 protein of avian viruses.
    Higuchi T; August JT
    Rev Bras Pesqui Med Biol; 1977; 10(1):1-14. PubMed ID: 190652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoassay of type D oncovirus from continuous J-96 cells.
    Vlasenkova NK; Kitsak VY; Altstein AD; Zhdanov VM
    Acta Virol; 1978 Jul; 22(4):257-62. PubMed ID: 80955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
    Salomon DS; Zwiebel JA; Noda M; Bassin RH
    J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of A-type intracytoplasmic particles produced by human cells].
    Kolobkov SL; Miller GG; Chernova OB; Kriukova IN
    Biull Eksp Biol Med; 1981 Mar; 91(3):324-7. PubMed ID: 6166336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between the loss of the transformed phenotype and an increase in superoxide dismutase activity in a revertant subclone of sarcoma virus-infected mammalian cells.
    Fernandez-Pol JA; Hamilton PD; Klos DJ
    Cancer Res; 1982 Feb; 42(2):609-17. PubMed ID: 6275983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and immunologic relationships among mammalian C-type viruses.
    Gilden RV; Oroszlan S
    J Am Vet Med Assoc; 1971 Mar; 158(6):Suppl 2:1099+. PubMed ID: 4103751
    [No Abstract]   [Full Text] [Related]  

  • 8. The reactions of monoclonal antibodies with structural proteins of mumps virus.
    Orvell C
    J Immunol; 1984 May; 132(5):2622-9. PubMed ID: 6201553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular localization of mammalian type C virus species-specific (gs-1) and interspecies-specific (gs-3) antigenic determinants with the indirect immunoperoxidase technique and light microscopy.
    Girardi A; Hampar B; Hsu KC; Oroszlan S; Hornberger E; Kelloff G; Gilden RV
    J Immunol; 1973 Jul; 111(1):152-6. PubMed ID: 4123368
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclic AMP-independent processes mediate Kirsten sarcoma virus-induced changes in collagen production and other properties of cultured cells.
    Majmudar G; Peterkofsky B
    J Cell Physiol; 1985 Jan; 122(1):113-9. PubMed ID: 2578130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bifunctional activity of transforming growth factor type beta on the growth of NRK-49F cells, normal and transformed by Kirsten murine sarcoma virus.
    Jullien P; Berg TM; de Lannoy C; Lawrence DA
    J Cell Physiol; 1988 Jul; 136(1):175-81. PubMed ID: 2840442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquity of natural antibodies to the mammary tumour virus in mice.
    Bentvelzen P; Brinkhof J
    Arch Geschwulstforsch; 1980; 50(3):193-203. PubMed ID: 6254462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of type C viral glycoproteins on P815 cells: higher expression of Mr 70,000 glycoprotein-containing glycoprotein on immunogenic variants.
    Jacquemin PC
    Cancer Res; 1982 Sep; 42(9):3828-36. PubMed ID: 6286113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of a sarcoma-growth-factor-like peptide from cells transformed by a temperature-sensitive sarcoma virus.
    De Larco JE; Preston YA; Todaro GJ
    J Cell Physiol; 1981 Oct; 109(1):143-52. PubMed ID: 6276416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by parvovirus H-1 of the formation of tumors in nude mice and colonies in vitro by transformed human mammary epithelial cells.
    Dupressoir T; Vanacker JM; Cornelis JJ; Duponchel N; Rommelaere J
    Cancer Res; 1989 Jun; 49(12):3203-8. PubMed ID: 2541900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression and localization of surface neoantigens in transformed and untransformed cultured cells infected with avian tumor viruses.
    Phillips ER; Perdue JF
    J Supramol Struct; 1976; 4(1):27-44. PubMed ID: 1256061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two cellular proteins that are precipitated by an antitumor-RSV rat serum.
    Grófová M; Forchhammer J; Mazurenko NN
    Neoplasma; 1982; 29(6):641-53. PubMed ID: 6298644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of intra- and extracellular transforming growth factors from normal and avian sarcoma virus-transformed rat cells.
    Yamaoka K; Hirai R
    Biochem Int; 1986 Nov; 13(5):863-72. PubMed ID: 3028422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of IFN-gamma-induced host cell MHC antigen expression by Kirsten MSV and MLV. II. Effects on class II antigen expression.
    Maudsley DJ; Morris AG
    Immunology; 1989 May; 67(1):26-31. PubMed ID: 2544514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies of a co-carcinogenic effect of vaccinia and herpes group viruses.
    Mazurenko NP; Merekalova ZI; Pavlish OA; Bykovsky AF; Kurzman MJ; Mazurenko NN
    Neoplasma; 1981; 28(4):403-12. PubMed ID: 6270580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.